Amneal Pharmaceuticals, Inc Class A Common Stock
Price & Volume
Stats
See more52W Range | $6.68-$10.34 |
Market Cap | $3B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $2.8B |
Revenue Growth (YoY) | 3.2% |
Gross Profit (12 Mos) | $1B |
Diluted EPS | $0.01 |
News
See moreYahoo Finance • 2 days ago
Amneal Receives U.S. FDA Approval for Bimatoprost Ophthalmic Solution, 0.01%
Yahoo Finance • 13 days ago
Amneal wins FDA nod for generic targeting Jazz Pharma’s Xyrem
Yahoo Finance • 20 days ago
Amneal gets FDA nod for generic version of Risperdal Consta
Yahoo Finance • 20 days ago
Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension
About
CEO | Mr. Chirag K. Patel |
CFO | Mr. Anastasios G. Konidaris |
Address | 400 Crossing Boulevard, Bridgewater, NJ, United States, 08807 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 8,300 |
